This job is closed
We regret to inform you that the job you were interested in has been closed. Although this specific position is no longer available, we encourage you to continue exploring other opportunities on our job board.
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancer harboring mutations in the RAS signaling pathway. The Vice President, Financial Planning & Analysis will be responsible for leading and evolving the Financial Planning & Analysis function. As a trusted business partner with senior leaders and across functions, they will determine how to support the rapid growth of the business. This role has accountability for managing financial planning, budgeting, consistent reforecasting, management reporting, preparing fact-based analytics, supporting corporate development initiatives, and developing value-add insights and analysis to drive and influence business decisions.